A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00257478

Enrollment

Unknown

Registered

2005-11-23

Start date

Unknown

Completion date

2007-03-31

Last updated

2012-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer of Prostate, Cancer of the Prostate, Prostate Cancer, Prostatic Cancer

Keywords

Treatment Efficacy, Treatment Effectiveness, Disease Management, Treatment, Safety

Brief summary

A study for the treatment of hormone refractory prostate cancer (HRPC) in patients previously treated with chemotherapy.

Interventions

DRUGYM155

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Histologically or cytologically confirmed prostate cancer. * Prior chemotherapy regimen for prostate cancer

Exclusion criteria

* History of other malignancy in the last 5 years * Major surgery within the past 21 days

Countries

Netherlands, United Kingdom, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026